1. Zak MYu. [IX Ukrainian gastroenterological week: new advances in the diagnosis and treatment of diseases of the digestive system]. Modern gastroenterology. 2016;6(92):7-11. Russian.
2. Nosach OV. Comorbidity and radiation: methodological aspects of health assessment of persons exposed to the Chornobyl accident factors. Probl Radiac Med Radiobiol. 2013;18:240-52.
3. Filippova AYu. [Disorders of oxidative metabolism and activity of enzymatic antioxidants in patients with non-alcoholic steatohepatitis combined with obesity and biliary tract pathology]. Ukrainian therapeutical journal. 2016;(3):19-26. Ukrainian.
4. Chernadchuk S. S. [Methods for assessing the state of the oxidative and antioxidant systems of biological objects: guidelines]. Odessa; 2011. 52 p. Russian.
5. Korolyuk MA, Ivanova LI, Mayorova IG, Tokarev VE. [Method for the determination of catalase activity]. Laboratornoe delo. 1988;(1):16-9. Russian.
6. Blyut EI. [Ultrasound diagnosis. A practical solution to clinical problems]. Moscow: Meditsinskaya literatura; 2011. 176 p. Russian.
7. Grigorieva IN, Romanova TI, Ragino YuI. [Peroxidation in patients with acute and chronic pancreatitis]. Experimental and Clinical Gastroenterology Journal. 2011;(7):24-7. Russian.
8. Nosach OV, Ovsyannikova LM, Chumak AA, Alekhina SM, Sarkisova EO, Hasanova OV, Pleskach OY, Nezhovorova GA, Zelinska AV, Kadyuk OM. Peculiarity of prooxidant-antioxidant balance indicators in patients with nonalcoholic fatty liver disease who have been exposed to ionizing radiation due to the Chornobyl NPP accident. Probl Radiac Med Radiobiol. 2015;20:420-31.
9. Backhed F. Programming of host metabolism by the gutmicrobiota. Ann Nutr Metab. 2011;58:44-52.
10. Plemmiannikova EV. [Metabolic syndrome in liquidators of the consequences of the Chernobyl accident] [dissertation]. St. Petersburg: The Federal State Budgetary Institute «The Nikiforov Russian Center of Emergency and Radiation Medicine»; 2011. 167 p.
11. Corrales F, Ochoa P, Rivas C. Inhibition of glutathione synthe sis in the liver leads to S-adenosyl-L-methionine synthetase reduction. J Hepatol. 1991;14:528-33.
12. Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1 Suppl):S47-64.
13. Vyalov SC. [Liver affection and comorbidities: a rational com bination of hepatoprotectors]. Russian Medical Journal. 2013;(31):16-21.
14. Gasanova OV, Sarkisova EO, Ovsyannikova LM, Chumak AA, Nosach OV, Nezgovorova GA, Gromadska VM. Structure of comorbid diseases in patients with non-alcoholic fatty liver disease, exposed to ionizing radiation as a result of the Chornobyl NPP accident. Probl Radiac Med Radiobiol. 2014;19:231-40.
15. Gasanova OV, Sarkisova EO, Chumak AA, Ovsyannikova LM, Nosach OV, Alohina SM, Gasanov VA, Kryzhanivska VV. Comparative characteristics of hepatoprotectors used for the treatment of non-alcoholic steatohepatitis associated with herpesvirus infection in sufferers of the Chornobyl accident. Probl Radiac Med Radiobiol. 2017;22:339-52.